ICD-10-CM code · FY2027
I25.85 Chronic coronary microvascular dysfunction
BillableValid for claims as a specific diagnosis code
About I25.85
EvidencePulse™by 2 Minute Medicine®
Go deeper into coronary artery disease.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for I25.85
Applicable to Other names for conditions reported with this code.
- Chronic (presentation of) coronary microvascular disease
- Coronary microvascular dysfunction NOS
Also applies, from I25 Chronic ischemic heart disease
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- non-ischemic myocardial injury (I5A)
Use additional code Add a second code for the detail named here.
Block I20-I25 notes (apply to every code in it)
Chapter 9 notes (apply to every code in it)
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- transient cerebral ischemic attacks and related syndromes (G45.-)
Related codes in I25.8
- I25.81 Atherosclerosis of other coronary vessels without angina pectorisHeader
- I25.82 Chronic total occlusion of coronary arteryBillable
- I25.83 Coronary atherosclerosis due to lipid rich plaqueBillable
- I25.84 Coronary atherosclerosis due to calcified coronary lesionBillable
- I25.89 Other forms of chronic ischemic heart diseaseBillable
Latest research on coronary artery disease
- Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease
- Patients with coronary artery disease have sustained elevation in blood pressure following exercise
- #VisualAbstract Edoxaban Monotherapy has Lower Risks for Atrial Fibrillation and Stable Coronary Artery Disease than Dual Antithrombotics
- Image-guided assessment of coronary inflammation improves cardiac risk prediction for patients without obstructive coronary artery disease
- Acceptance and commitment therapy not associated with different outcomes in patients with coronary artery disease
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app